Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -172.58% is 110% below its 5-year average of -82.10%, near the low end of its 5-year range (-179.71%–-23.09%).
16.29% below its 12-month average of -148.41%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -25.94%.
RETURN ON ASSETS (ROA)
-172.58%
RETURN ON ASSETS (ROA) AVG TTM
-148.41%
RETURN ON ASSETS (ROA) AVG 3Y
-106.72%
RETURN ON ASSETS (ROA) AVG 5Y
-82.10%
RETURN ON ASSETS (ROA) AVG 10Y
-73.88%
RETURN ON ASSETS (ROA) AVG 15Y
-62.08%
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
-16.29%
CURRENT VS 3Y AVG
-61.71%
CURRENT VS 5Y AVG
-110.20%
CURRENT VS 10Y AVG
-133.59%
CURRENT VS 15Y AVG
-178.00%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.24%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-435.30%
vs the sector median at left
Sintx Technologies, Inc.
Market Cap
$13.86M
Return on Assets (ROA)
-172.58%
TTM Avg
-148.41%
3Y Avg
-106.72%
5Y Avg
-82.10%
Market Cap
$13.75M
Return on Assets (ROA)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$14.05M
Return on Assets (ROA)
-15.57%
TTM Avg
-20.73%
3Y Avg
-20.84%
5Y Avg
-41.87%
Market Cap
$13.33M
Return on Assets (ROA)
-85.85%
TTM Avg
-102.78%
3Y Avg
-95.22%
5Y Avg
-76.09%
Market Cap
$13.30M
Return on Assets (ROA)
-27.12%
TTM Avg
-32.94%
3Y Avg
-35.27%
5Y Avg
-29.16%
Market Cap
$14.46M
Return on Assets (ROA)
-123.23%
TTM Avg
-153.35%
3Y Avg
-205.77%
5Y Avg
-166.29%
Market Cap
$13.20M
Return on Assets (ROA)
-32.53%
TTM Avg
-31.07%
3Y Avg
-30.77%
5Y Avg
-29.89%
Market Cap
$13.11M
Return on Assets (ROA)
-143.44%
TTM Avg
-68.17%
3Y Avg
-65.00%
5Y Avg
-57.74%
Market Cap
$14.73M
Return on Assets (ROA)
-201.89%
TTM Avg
-113.65%
3Y Avg
-83.24%
5Y Avg
-72.72%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sintx Technologies, Inc. (SINT) | $13.86M | -172.58% | -148.41% | -106.72% | -82.10% |
| Obsidian Therapeutics Inc. (OBX)vs › | $13.75M | N/A | N/A | N/A | N/A |
| Pulsenmore Ltd. Ordinary Shares (PLSM)vs › | $14.05M | -15.57% | -20.73% | -20.84% | -41.87% |
| IN8bio, Inc. (INAB)vs › | $13.33M | -85.85% | -102.78% | -95.22% | -76.09% |
| Optimi Health Corp. (OPTH)vs › | $13.30M | -27.12% | -32.94% | -35.27% | -29.16% |
| Vyome Holdings, Inc. (HIND)vs › | $14.46M | -123.23% | -153.35% | -205.77% | -166.29% |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $13.20M | -32.53% | -31.07% | -30.77% | -29.89% |
| Passage Bio, Inc. (PASG)vs › | $13.11M | -143.44% | -68.17% | -65.00% | -57.74% |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $14.73M | -201.89% | -113.65% | -83.24% | -72.72% |
| Pasithea Therapeutics Corp. (KTTA)vs › | $14.94M | -41.18% | -60.23% | -53.11% | -40.22% |
ROA
-172.6%
ROE
-372.7%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -179.71% |
| 2024-12-31 | -117.11% |
| 2023-12-31 | -53.75% |
| 2022-12-31 | -76.33% |
| 2021-12-31 | -42.62% |
| 2020-12-31 | -23.09% |
| 2019-12-31 | -52.44% |
| 2018-12-31 | -75.14% |
| 2017-12-31 | -63.72% |
| 2016-12-31 | -63.20% |
| 2015-12-31 | -65.59% |
| 2014-12-31 | -68.47% |
| 2013-12-31 | -24.14% |
| 2012-12-31 | -104.72% |
| 2011-12-31 | -38.80% |
